Teamed up to innovate
Lab Matters A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
2022
lab-matters
Investing in Italy by translating EMBL expertise to the market
Alumni, Lab Matters, Technology and innovation Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
2022
alumnilab-matterstechnology-and-innovation
Structural biology at EMBL: driving technology development
Lab Matters Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
2021
lab-matters
ALPX – smart crystallography
Lab Matters The CrystalDirect® technology, combined with the web-based CRIMS software enable a fully automated, remote-controlled protein-to-structure pipeline.
2020
lab-matters
Twenty years of EMBLEM
Lab Matters Reflecting on 20 years of EMBLEM
2019
lab-matters
EMBL spinoff to help antibody discovery
Lab Matters New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-matters
EMBL spin-off Luxendo acquired by Bruker
Lab Matters Accelerating researchers’ access to next-generation light-sheet microscopy
2017
lab-matters
New EMBL and GSK collaboration
Lab Matters GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
2017
lab-matters
SPIM doctors
Science From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
2015
science
Lighting the way
Lab Matters A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
2015
lab-matters
The transparent organism
Lab Matters A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…
2005
lab-matters
No matching posts found
